cbdMD Management
Management criteria checks 3/4
cbdMD's CEO is T. Kennedy, appointed in Oct 2020, has a tenure of 5.17 years. total yearly compensation is $300.00K, comprised of 91.7% salary and 8.3% bonuses, including company stock and options. directly owns 5.45% of the company’s shares, worth $816.82K. The average tenure of the management team and the board of directors is 5.2 years and 3.3 years respectively.
Key information
T. Kennedy
Chief executive officer
US$300.0k
Total compensation
| CEO salary percentage | 91.67% |
| CEO tenure | 5.2yrs |
| CEO ownership | 5.5% |
| Management average tenure | 5.2yrs |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
cbdMD (NYSEMKT:YCBD) Has Debt But No Earnings; Should You Worry?
Mar 23
This Insider Has Just Sold Shares In cbdMD, Inc. (NYSEMKT:YCBD)
Feb 23If You Had Bought cbdMD (NYSEMKT:YCBD) Stock A Year Ago, You Could Pocket A 383% Gain Today
Feb 09We Wouldn't Rely On cbdMD's (NYSEMKT:YCBD) Statutory Earnings As A Guide
Jan 13Is cbdMD (NYSEMKT:YCBD) Using Debt Sensibly?
Dec 15
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2025 | US$300k | US$275k | -US$4m |
| Jun 30 2025 | n/a | n/a | -US$5m |
| Mar 31 2025 | n/a | n/a | -US$4m |
| Dec 31 2024 | n/a | n/a | -US$7m |
| Sep 30 2024 | US$275k | US$275k | -US$8m |
| Jun 30 2024 | n/a | n/a | -US$23m |
| Mar 31 2024 | n/a | n/a | -US$26m |
| Dec 31 2023 | n/a | n/a | -US$24m |
| Sep 30 2023 | US$275k | US$275k | -US$27m |
| Jun 30 2023 | n/a | n/a | -US$26m |
| Mar 31 2023 | n/a | n/a | -US$56m |
| Dec 31 2022 | n/a | n/a | -US$59m |
| Sep 30 2022 | US$558k | US$276k | -US$74m |
| Jun 30 2022 | n/a | n/a | -US$63m |
| Mar 31 2022 | n/a | n/a | -US$29m |
| Dec 31 2021 | n/a | n/a | -US$37m |
| Sep 30 2021 | US$720k | US$247k | -US$26m |
Compensation vs Market: T.'s total compensation ($USD300.00K) is below average for companies of similar size in the US market ($USD575.90K).
Compensation vs Earnings: T.'s compensation has increased whilst the company is unprofitable.
CEO
T. Kennedy (46 yo)
Mr. T. Ronan Kennedy has been the Chief Financial Officer at cbdMD, Inc., since October 1, 2020 and serves as its Chief Executive Officer since Oct 2025 and was Interim Chief Executive Officer and Principa...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, CFO | 5.2yrs | US$300.00k | 5.45% $ 816.8k | |
| Chief Accounting Officer | 1.8yrs | US$207.31k | 0.00059% $ 88.4 | |
| CSO, VP of Regulatory Affairs & Director | no data | US$115.06k | 0.011% $ 1.6k | |
| Chief Technology Officer | 6.9yrs | no data | no data | |
| General Counsel | 7yrs | no data | no data | |
| Senior VP of Sales | 7.1yrs | no data | no data | |
| Chief Marketing Officer | 2.9yrs | no data | no data | |
| Senior VP of Business Development | 4yrs | no data | no data |
Experienced Management: YCBD's management team is seasoned and experienced (5.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, CFO | 1yr | US$300.00k | 5.45% $ 816.8k | |
| CSO, VP of Regulatory Affairs & Director | 3.3yrs | US$115.06k | 0.011% $ 1.6k | |
| Independent Director | less than a year | US$20.79k | 0.14% $ 21.4k | |
| Independent Chairman | 6.7yrs | US$71.12k | 0.013% $ 2.0k | |
| Independent Director | 6.7yrs | US$57.20k | 0.11% $ 16.7k | |
| Independent Director | 8.8yrs | US$47.52k | 0.013% $ 1.9k | |
| Independent Director | less than a year | US$23.01k | 0.031% $ 4.7k |
Experienced Board: YCBD's board of directors are considered experienced (3.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/26 15:06 |
| End of Day Share Price | 2025/12/24 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
cbdMD, Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Hickey | Benchmark Company |
| William Sutherland | Benchmark Company |
| Anthony Vendetti | Maxim Group |